US Department of Commerce Issues Guidance on Tariff Adjustments for Specialty Pharmaceuticals and Associated Ingredients

Summary

The US Department of Commerce has released a notice outlining procedures for implementing tariff adjustments for specialty pharmaceuticals and associated ingredients, as well as technical corrections to the Harmonized Tariff Schedule of the United States, in response to Presidential Proclamation 11020, which aims to reduce tariffs on certain pharmaceutical imports